Inverness Medical Innovations (IMA) Posts Q3 EPS of $0.74
More News related to IMA
- To Manage Weight Over the Holidays, Experts From Alere Say Enjoy, Indulge a Little and Don't Diet!
- OraSure Tech (OSUR) Settles Patent Infringement Suit with Inverness (IMA), Inverness Switzerland, and Church & Dwight (CHD)
- OraSure Tech (OSUR) Settles Patent Infringement Suit with Inverness (IMA), Inverness Switzerland, and Church & Dwight (CHD)
- Alere Secures Prestigious NCQA Accreditation for Wellness & Health Promotion
- OraSure Technologies Announces Settlement of Patent Infringement Lawsuit With Inverness and Church & Dwight
Inverness Medical Innovations Inc. (NYSE: IMA) reports Q3 EPS of $0.74, versus the analyst estimate of $0.61. Revenue for the quarter was $ million, which compares to the estimate of $491.73 million.
Related Categories
EarningsStocks Mentioned
-0.32Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
